Ropes & Gray represented Viridian Therapeutics, Inc. in the offering, and Wilmer Cutler Pickering Hale and Dorr represented the underwriters. Viridian Therapeutics, Inc. (Nasdaq: VRDN), a...
You must be a Standard 1 Year member to access this content.
Cooley advised Janux Therapeutics on the offering and Wilson Sonsini Goodrich & Rosati advised Janux on patent matters. Latham & Watkins advised the underwriters. Janux Therapeutics,...
You must be a Standard 1 Year member to access this content.
Cooley advised Instacart, and Latham & Watkins advised the underwriters. Maplebear Inc. d/b/a Instacart announced the pricing of its initial public offering of 22,000,000 shares of its...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Morgan Stanley & Co. LLC and Wedbush Securities Inc. on the offering. TScan Therapeutics, a biopharmaceutical company, has announced a $140.6 million SEC-registered common...
You must be a Standard 1 Year member to access this content.
Cooley advised Geron, while Latham & Watkins represented the underwriters in the offering. Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, has announced the pricing...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented the underwriters and placements agents in the transaction. Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, has announced...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Alpine, while Latham & Watkins represented to underwriters in the offering. Alpine Immune Sciences, Inc. (Nasdaq: ALPN) has announced the pricing...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented IDEAYA, while Davis Polk advised the representatives of the several underwriters in the offering. IDEAYA Biosciences, Inc. (Nasdaq: IDYA) announced the pricing of an...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the underwriters in the offering. Chinook Therapeutics, Inc. (Nasdaq: KDNY) has announced the pricing of its underwritten public offering of 6,428,572 shares...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the joint book-running managers in the offering. Tellurian Inc. executed its offering of $50 million principal amount of 8.250% senior notes due 2028. The net...
You must be a Standard 1 Year member to access this content.
Cleary Gottlieb Steen & Hamilton represented GlobalFoundries in the offering, while Latham & Watkins represented the underwriters. GlobalFoundries® (GF®), a global leader in feature-rich semiconductor manufacturing, announced...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Rivian Automotive, while Skadden, Arps, Slate, Meagher & Flom advised the underwriters in the Initial Public Offering. Rivian Automotive, Inc. has announced its...
You must be a Standard 1 Year member to access this content.
